4.6 Article

Quantitative Assessment of Finger Motor Impairment in Multiple Sclerosis

Journal

PLOS ONE
Volume 8, Issue 5, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0065225

Keywords

-

Funding

  1. Italian Multiple Sclerosis Foundation (FISM) [2011/R/7, 2011/R/8]
  2. Biogen Idec
  3. Merck Serono
  4. Synthon
  5. Actelion
  6. Allozyne
  7. Bayer Schering
  8. Sanofi-Aventis
  9. Novartis
  10. Allergan
  11. Roche
  12. Teva

Ask authors/readers for more resources

Objective: To address the disability impact on fine hand motor functions in patients with Multiple Sclerosis (MS) by quantitatively measuring finger opposition movements, with the aim of providing a new score'' integrating current methods for disability assessment. Methods: 40 MS patients (Expanded Disability Status Scale (EDSS): 0-7) and 80 healthy controls (HC) performed a repetitive finger-to-thumb opposition sequence with their dominant hand at spontaneous and maximal velocity, and uni- and bi-manually metronome-paced. A sensor-engineered glove was used to measure finger motor performance. Twenty-seven HC were tested twice, one month apart, to assess test-retest reliability. Results: The motor parameters showed a good reproducibility in HC and demonstrated significantly worse performance in MS patients with respect to HC. A multivariate model revealed that rate of movement in the spontaneous velocity condition and inter-hand interval (IHI), indicating bimanual coordination, contributed independently to differentiate the two groups. A finger motor impairment score based on these two parameters was able to discriminate HC from MS patients with very low EDSS scores (p<0.001): a significant difference was already evident for patients with EDSS = 0. Further, in the MS group, some motor performance parameters correlated with the clinical scores. In particular, significant correlations were found between IHI and EDSS (r = 0.56; p<0.0001), MS Functional Composite (r = -0.40; p = 0.01), Paced Auditory Serial Addition (r = -0.38; p = 0.02). No motor performance parameter correlated with Timed 25-Foot Walk. Conclusions: A simple, quantitative, objective method measuring finger motor performance could be used to define a score discriminating healthy controls and MS patients, even with very low disability. This sensitivity might be of crucial importance for monitoring the disease course and the treatment effects in early MS patients, when changes in the EDSS are small or absent.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Correlation between patient-reported manual ability and three objective measures of upper limb function in people with multiple sclerosis

Claudio Solaro, Rachele Di Giovanni, Erica Grange, Giampaolo Brichetto, Margit Mueller, Andrea Tacchino, Rita Bertoni, Francesco Patti, Angelo Pappalardo, Luca Prosperini, Letizia Castelli, Rosalba Rosato, Davide Cattaneo, Davide Marengo

Summary: The study aims to evaluate the associations between Manual Ability Measure-36 (MAM-36) and objective measures, including the Nine Hole Peg Test (9-HPT), Box and Block Test (BBT), and Hand Grip Strength (HGS) in people with multiple sclerosis (PwMS). The study found small correlations between MAM-36 and these objective measures, with different correlations seen in different subgroups. Combining 9-HPT and HGS can enhance the assessment of upper limb function in daily activities.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

Darin T. Okuda, Orhun Kantarci, Christine Lebrun-Frenay, Maria Pia Sormani, Christina J. Azevedo, Francesca Bovis, Le H. Hua, Lilyana Amezcua, Ellen M. Mowry, Christophe Hotermans, Jason Mendoza, John S. Walsh, Christian von Hehn, Wendy S. Vargas, Stacy Donlon, Robert T. Naismith, Annette Okai, Gabriel Pardo, Pavle Repovic, Olaf Stuve, Aksel Siva, Daniel Pelletier

Summary: This study evaluated the impact of therapeutic intervention in preventing the first symptom manifestation in individuals with radiologically isolated syndrome (RIS), the pre-clinical phase of multiple sclerosis (MS). The results showed that drug treatment significantly reduced the risk of clinical symptoms.

ANNALS OF NEUROLOGY (2023)

Article Clinical Neurology

Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series study

Vincenzo Daniele Boccia, Caterina Lapucci, Maria Cellerino, Francesco Tazza, Andrea Rossi, Simona Schiavi, Maria Margherita Mancardi, Matilde Inglese

Summary: The contribution of the central vein sign (CVS) to the diagnosis of multiple sclerosis (MS) was compared between pediatric-onset (POMS) and adult-onset (AOMS) patients. The study found that CVS had lower sensitivity in POMS patients, possibly due to the exclusion of a high proportion of periventricular confluent lesions from CVS assessment.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Clinical Neurology

CD19 thorn B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis

Irene Schiavetti, Lucrezia Barcellini, Caterina Lapucci, Francesco Tazza, Maria Cellerino, Elisabetta Capello, Diego Franciotta, Matilde Inglese, Maria Pia Sormani, Antonio Uccelli, Alice Laroni

Summary: This exploratory study found that the increase in anti-SARS-CoV2 antibodies following the third dose of COVID-19 vaccination in fingolimod-treated MS patients may be correlated to lymphocyte subsets and demographic features. Specifically, the percentage of CD19+ B lymphocytes was found to be associated with the increase in antibody levels. Therefore, evaluating the percentage of CD19+ B cells may be important in identifying patients at risk of reduced protection from COVID-19.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2023)

Article Clinical Neurology

Brain FDG-PET findings in chimeric antigen receptor T-cell therapy neurotoxicity for diffuse large B-cell lymphoma

Silvia Morbelli, Massimiliano Gambella, Anna Maria Raiola, Chiara Ghiggi, Matteo Bauckneht, Tania Di Raimondo, Caterina Lapucci, Gianmario Sambuceti, Matilde Inglese, Emanuele Angelucci

Summary: This study evaluated the brain metabolic effects of CAR-T cell therapy in diffuse large B-cell lymphoma patients, finding that CRS and ICANS lead to different patterns of brain metabolism, with ICANS patients showing more extensive metabolic abnormalities in the frontal and temporal lobes.

JOURNAL OF NEUROIMAGING (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection

Piet M. Bouman, Samantha Noteboom, Fernando A. Nobrega Santos, Erin S. Beck, Gregory Bliault, Marco Castellaro, Massimiliano Calabrese, Declan T. Chard, Paul Eichinger, Massimo Filippi, Matilde Inglese, Caterina Lapucci, Andrzej Marciniak, Bastiaan Moraal, Alfredo Morales Pinzon, Mark Muehlau, Paolo Preziosa, Daniel S. Reich, Maria A. Rocca, MennoM. Schoonheim, Jos W. R. Twisk, Benedict Wiestler, Laura E. Jonkman, Charles R. G. Guttmann, Jeroen J. G. Geurts, Martijn D. Steenwijk

Summary: This study evaluated the detection ability of artificial intelligence-generated double inversion recovery (DIR) and phase-sensitive inversion recovery (PSIR) images for cortical and juxtacortical multiple sclerosis lesions in a multicenter setting, compared with MRI-acquired images. The results showed that the AI-generated images performed well compared to the MRI-acquired images and demonstrated good reliability in a multicenter setting, with good interpretative agreement between readers and centers.

RADIOLOGY (2023)

Article Clinical Neurology

Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Cognition in Multiple Sclerosis

Maria Pia Sormani, Irene Schiavetti, Marta Ponzano, Elisa Colato, Nicola De Stefano

Summary: The objective of this study was to assess the mediating effect of treatment on MRI-derived measures of brain atrophy and focal lesions on cognitive outcomes in MS clinical trials. The study analyzed published randomized trials in MS lasting at least 2 years and found that treatment effect on cognitive performance was strongly associated with the treatment effect on brain atrophy, but not with active MRI lesions. These results suggest that brain atrophy can be a main outcome measure for clinical trials targeting cognitive impairment and neurodegeneration in MS.

ANNALS OF NEUROLOGY (2023)

Review Clinical Neurology

Enhancing diversity of clinical trial populations in multiple sclerosis

Ruth Ann Marrie, Jeremy Chataway, Barbara E. Bierer, Marcia Finlayson, Elena H. Martinez-Lapiscina, Jennifer Panagoulias, Maria Pia Sormani, Mitzi Joi Williams, Lilyana Amezcua

Summary: This article summarizes recommendations for enhancing diversity and inclusion in clinical trials for multiple sclerosis (MS), including the use of diversity plans, community engagement and education, cultural competency training, adaptive designs, and reducing participant burden.

MULTIPLE SCLEROSIS JOURNAL (2023)

Review Clinical Neurology

Assessing heterogeneity of treatment effect in multiple sclerosis trials

Maria Pia Sormani, Jeremy Chataway, David M. Kent, Ruth Ann Marrie

Summary: Multiple sclerosis (MS) has varied outcomes, and evaluating heterogeneity of treatment effect (HTE) is important. Various statistical techniques can assess HTE, with multivariable predictive approaches offering more patient-centered results. This review examines methods used to estimate HTE in MS clinical trials.

MULTIPLE SCLEROSIS JOURNAL (2023)

Review Clinical Neurology

Improving the efficiency of clinical trials in multiple sclerosis

Ruth Ann Marrie, Maria Pia Sormani, Sean Apap Mangion, Francesca Bovis, Winson Y. Cheung, Gary R. Cutter, Peter Feys, Michael D. Hill, Marcus Werner Koch, Morgan McCreary, Ellen M. Mowry, Jay J. H. Park, Fredrik Piehl, Amber Salter, Jeremy Chataway

Summary: The current designs for clinical trials treating progressive multiple sclerosis (MS) have limitations and have not been successful. This paper discusses complex innovative trial designs and intermediate and composite outcomes to improve trial design efficiency in MS. Recommendations include increasing the use of complex innovative designs, developing biomarkers to enrich trial populations, prioritizing intermediate outcomes targeting therapeutic mechanisms, and investigating data linkage for long-term outcomes. Novel trial designs and further development of intermediate outcomes may improve clinical trial efficiency and address novel therapeutic questions in MS.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Neurosciences

Don't plan, just do it: Cognitive and sensorimotor contributions to manual dexterity

Laura Bonzano, Monica Biggio, Sabrina Brigadoi, Ludovico Pedulla, Monica Pagliai, Costanza Iester, Giampaolo Brichetto, Simone Cutini, Marco Bove

Summary: This study used fNIRS to investigate cortical activations during the execution of a manual dexterity test. The results showed that participants with a larger execution time difference had higher activation in prefrontal cortical areas, and there was a significant linear relationship between Delta HPT and right BA10 activity.

NEUROIMAGE (2023)

Article Clinical Neurology

The administration of the paper and electronic versions of the Manual Ability Measure-36 (MAM-36) and Fatigue Severity Scale (FSS) is equivalent in people with multiple sclerosis

Andrea Tacchino, Rachele Di Giovanni, Erica Grange, Maria Marcella Spirito, Michela Ponzio, Mario Alberto Battaglia, Giampaolo Brichetto, Claudio Marcello Solaro

Summary: This study evaluates the equivalence between paper-and-pencil and electronic versions of patient-reported outcome (PRO) measures in people with multiple sclerosis (PwMS). The results suggest a high level of equivalence between the two versions, and show that PwMS prefer the electronic method.

NEUROLOGICAL SCIENCES (2023)

Article Medicine, General & Internal

Development and psychometric properties of a self-assessed knowledge questionnaire for caregivers of people with multiple sclerosis (CareKoMS): a cross-sectional study

Jessica Podda, Andrea Tacchino, Anna Verri, Mario Alberto Battaglia, Giampaolo Brichetto, Michela Ponzio

Summary: The aim of this study was to develop and validate the Caregivers' Knowledge of Multiple Sclerosis (CareKoMS), a self-assessed questionnaire, to test MS knowledge in caregivers of people with MS. The results indicate that CareKoMS is a reliable self-assessed questionnaire that can be used in clinical practice and research.

BMJ OPEN (2023)

Article Health Care Sciences & Services

Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis

Marissa Betts, Kyle Fahrbach, Binod Neupane, Mahmoud Slim, Maria Pia Sormani, Gary Cutter, Thomas P. A. Debray, Marvin Rock

Summary: This study evaluates eight approaches for handling overlapping publications in network meta-analyses of real-world evidence (RWE) studies and recommends establishing an a priori hierarchy for selection.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2023)

Article Health Care Sciences & Services

An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study

Andrea Tacchino, Michela Ponzio, Paolo Confalonieri, Letizia Leocani, Matilde Inglese, Diego Centonze, Eleonora Cocco, Paolo Gallo, Damiano Paolicelli, Marco Rovaris, Loredana Sabattini, Gioacchino Tedeschi, Luca Prosperini, Francesco Patti, Placido Bramanti, Elisabetta Pedrazzoli, Mario Alberto Battaglia, Giampaolo Brichetto

Summary: This paper describes the design, development, and usability testing of MS Fitness Intervention Training (MS-FIT), a Kinect-based tool implementing customized Pilates exercises for people with MS. The user-centered design approach was used to create an accessible and challenging tool for balance training. The usability testing showed that MS-FIT is a promising system for enhancing the motivation and engagement of people with MS in performing exercises.

JMIR SERIOUS GAMES (2023)

No Data Available